Cyclerion Therapeutics (CYCN) Treasury Shares (2019 - 2025)
Historic Treasury Shares for Cyclerion Therapeutics (CYCN) over the last 7 years, with Q3 2025 value amounting to $119102.0.
- Cyclerion Therapeutics' Treasury Shares fell 3353.61% to $119102.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $119102.0, marking a year-over-year decrease of 3353.61%. This contributed to the annual value of $164174.0 for FY2024, which is 395.64% down from last year.
- According to the latest figures from Q3 2025, Cyclerion Therapeutics' Treasury Shares is $119102.0, which was down 3353.61% from $134126.0 recorded in Q2 2025.
- Cyclerion Therapeutics' Treasury Shares' 5-year high stood at $809417.0 during Q1 2023, with a 5-year trough of $34362.0 in Q2 2023.
- Over the past 5 years, Cyclerion Therapeutics' median Treasury Shares value was $134126.0 (recorded in 2025), while the average stood at $159839.0.
- Per our database at Business Quant, Cyclerion Therapeutics' Treasury Shares crashed by 7459.84% in 2022 and then skyrocketed by 46522.32% in 2024.
- Cyclerion Therapeutics' Treasury Shares (Quarter) stood at $92804.0 in 2021, then tumbled by 56.07% to $40772.0 in 2022, then soared by 319.25% to $170937.0 in 2023, then decreased by 3.96% to $164174.0 in 2024, then fell by 27.45% to $119102.0 in 2025.
- Its Treasury Shares stands at $119102.0 for Q3 2025, versus $134126.0 for Q2 2025 and $149150.0 for Q1 2025.